Placenta is the vascular organ in most mammals that connects the fetus to the uterus of the mother. It mediates the metabolic exchanges of the developing individual through an intimate association of embryonic tissues and of specific uterine tissues, which serve the functions of respiration, nutrition, and excretion.
Portland, OR -- (SBWIRE) -- 09/13/2017 -- The advantages associated with placenta augment the market growth. A surge in the demand for anti-aging and skin rejuvenating treatments are the key factors that propel the placenta market. However, ethical issues and stringent regulations towards the use of placenta impede the growth of the market.
Access full summary at :https://www.alliedmarketresearch.com/placenta-market
The global placenta market is segmented on the basis of type, application, and geography. Based on type, it is bifurcated into porcine, equine, ovine, and others. On the basis of application, the market is divided into pharmaceuticals, cosmetics, supplements, and others. By geography, it has been analysed across North America, Europe, Asia-Pacific, and LAMEA.
Comprehensive competitive analysis and profiles of major market players such as
Japan Bio Products Co., Ltd., CJT, BIOON, Japan Natural Laboratories Co., Ltd, Brooklyn Placenta Services, LLC, MiMedx Group, Inc., Atlanta Placenta, and telaGen have been provided in this report.
Get PDF Brochure of this report: https://www.alliedmarketresearch.com/request-toc-and-sample/3715
Placenta Market Key Segments:
By Type
- Porcine
- Equine
- Ovine
- Others
By Application
- Pharmaceuticals
- Cosmetics
- Supplements
- Others
Early buyers will receive 20% customization on this report